| Market Cap | ₹64Cr |
| ROE | 4.59% |
| P/E Ratio(TTM) | 53.82 |
| EPS(TTM) | 0.50 |
| P/B Ratio | 2.45 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.81 |
| Book Value | 10.96 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
| Parent Organisation | Kabra Drugs Limited |
| Managing Director | N. ARAVIND |
| Founded | 1989 |
| BSE Symbol | 524322 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.46 | ||
| Ajanta Pharma | NA (0.00%) | 33.38 | ||
| Gland Pharma | NA (0.00%) | 34.73 | ||
| Eris Lifesciences | NA (0.00%) | 47.12 |